Aspergillus galactomannan antigen detection, bronchoalveolar lavage (BAL) or serum

Alphabetical Test listing

Aspergillus galactomannan antigen detection, bronchoalveolar lavage (BAL) or serum-13548

  
Aspergillus galactomannan antigen detection, bronchoalveolar lavage (BAL) or serum
  
13548
  
LAB13548
  
ASG
  
A. fynugatys
Aspergillus Ag, BAL/Serum
  

Patients diagnosed with chronic granulomatous disease and/or Job's syndrome may yield a reduced detection of galactomannan

  
Serum
  
  
2.0 mL
  
0.35 mL
Submission of the minimum volume does not allow for repeat testing
  
  • Collect specimen using aseptic technique
  • Immediately following collection, mix sample thoroughly by gentle inversion, 5 times
  
  1. Allow sample to clot for a minimum of 30 minutes
  2. Spin within two (2) hours of sample collection

AVOID opening the specimen after collection to prevent contamination with fungal spores and/or bacteria present in the environment (transport in sealed tubes).

  

Gold serum separator (SST) tube

Note: Pour-off specimens and specimens sent in non-sterile containers will be rejected due to the risk of false positive results.

  
Bronchoalveolar lavage (BAL)
  
  
2.0 mL
  

Note: If an aliquoting step cannot be avoided, aliquot within a well maintained biosafety cabinet using sterile technique. Avoid opening the specimen after collection to prevent the environment.

  

Sterile container

Note: Submissions in non-sterile containers or containers without a secure screw cap will be rejected

  

Serum:

Refrigerated (unopened) - 5 days

Frozen - 5 months

     Freeze/thaw cycle: Stable x4

Ambient - NO

BAL:

Refrigerated (Unopened) - 24 hours

Frozen - 5 months

     Freeze/thaw cycle: Stable x4

Ambient - NO

  
  • Unlabeled specimen or name discrepancy between specimen and test request form
  • Blood collected in collection tubes other than those specified
  • Grossly hemolyzed, lipemic, or icteric blood specimens
  • Respiratory specimens other than BAL
  • Inadequate specimen volume
  • Specimen received after the specified time or improperly stored/transported
  • Specimen source other than BAL or serum
  • Specimens submitted in non-sterile containers
  
LabCorp Burlington (183805): R-LC
  
Mo, We, Fr
  
2 - 5 days
  

Enzyme immunoassay (EIA)

  

0.00 - 0.49 Index

  

Reduced assay sensitivity may occur in patients receiving concomitant antifungal therapy. Penicillium species, Alternaria species, Paecilomyces species, Geotrichum species, and Histoplasma species have demonstrated reactivity with the monoclonal antibodies used in the assay and may, therefore, yield a positive test result.

Positive results in patients with no clinical signs of disease have been reported, especially in young children. Most of these are considered to be false positives. Young children may have a positive assay result due to the presence of galactofuranaase contained in various foods (cereals) and milk. Patients receiving piperacillin/tazobactam or semisynthetic beta-lactamase therapy may have false-positive results. False-positive results may also occur with use of PLASMA-LYTE(TM) for either intravenous hydration or BAL specimen collection.

  
Submission of specimens poured off, or specimens sent in non-sterile containers is not recommended as this can lead to false positive results.
  
87305
  
Result 62467-6
  
03/27/2019
  
07/16/2024
  
12/26/2023